Effect of antenatal corticosteroids in late preterm delivery on neonatal morbidity: A Randomised Controlled Trial

Main Article Content

Anisah Yahya
Hajaratu Umar Sulayman
Isah Abdulkadir
Bola Biliaminu Lawal


antenatal corticosteroids, late preterm delivery, neonatal morbidity


Background: The use of antenatal corticosteroids beyond 34 weeks of gestation to prevent neonatal complications remains a debate. This study sought to determine the effect of the use of antenatal corticosteroids in late preterm delivery on neonatal morbidity.

Method: A randomized double-blind placebo and active-controlled multi-arm trial. There were two study groups and one control group. It was conducted at the Department of Obstetrics and Gynaecology and the Department of Paediatrics of Ahmadu Bello University Teaching Hospital Zaria, Nigeria. Pregnant women at 34 weeks to 36 weeks 6 days of gestation scheduled delivery were recruited for the study.

The first study group had 2 doses of 12mg intramuscular dexamethasone and the second study group had 2 doses of 12mg betamethasone.  The control group had 2 doses of a placebo. The primary outcome was the incidence of respiratory distress syndrome evidenced by tachypnoea with grunting, recession, or nasal flaring with diffuse reticulogranular infiltrate on X-ray or respiratory distress requiring the need for respiratory support by 72 hours of age. Secondary outcome measures included need for neonatal resuscitation at birth, admission into the Special Care Baby Unit/Neonatal Intensive Care Unit, transient tachypnoea of the newborn, apnoea, and neonatal hypoglycemia.

Results: A total of 138 mothers and 146 preterm neonates were included.  Pairwise analysis was done to test for differences between the groups. There was no difference in the incidence of respiratory distress syndrome between the groups. However, the need for neonatal resuscitation was significantly higher (RR: 7.0; CI: 2.49-19.4; p = <0.001) in the placebo group when compared to the betamethasone group and also significantly higher (RR:4.0; CI: 1.86-26.03; p= 0.01) in the placebo group when compared to the betamethasone group.

Conclusion: Antenatal corticosteroids may decrease the need for neonatal resuscitation at birth in late preterm neonates.





Abstract 31 | PDF Downloads 22 HTML Downloads 4


1. Crowley P. Antenatal corticosteroids:A meta-analysis of randomised trial. Am J Obs Gynecol.1995;173:322–35.

2. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst Rev.2006;(3):No.: CD004454.

3. Escobar G, Clark RH, Greene J. Short-term outcomes of infants born at 35 and 36 weeks gestation: we need to ask more questions. Semin Perinatol. 2006;30(1):28–33.

4. Berman S, Tanasijevic MJ, Alvarez JG, Ludmir J, Lieberman E, Richardson DK. Racial differences in the predictive value of the TDx fetal lung maturity assay. Am J Obs Gynecol. 1996;175:73–77.

5. Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ. 2016;i5044.

6. Null N. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am. J. Obstet. Gynecol. 2016;215:B13–B15. doi: 10.1016/j.ajog.2016.03.0131972;50:515–525.

7. Hibbard JU. Respiratory morbidity in late preterm births. J Am Med Assoc. 2010;304(4):419–425.

8. Raju T, Higgins R. Optimising care and outcome for late preterm (near term) infants. Summary of workshop sponsored by the national institute of child health and human development. Pediatrics. 2006;118:1207–1214.

9. Juszczak E, Altman D, Hopewell S, Schulz K. Reporting of Multi-Arm Parallel-Group Randomized Trials Extension of the CONSORT 2010 Statement. Clinical Review. 2019;321(16):1610–20.

10. Porto A. Effectiveness of antenatal corticosteroids in decreasing respiratory disorders in late preterm infants. Randomised controlled trial. BMJ. 2011;342:d1696.

11. Balci O. The effect of antenatal corticosteroid in fetal lung maturation between 34th and 36th week of pregnancy. Gynecol Obs Invest. 2010;70:95–99.

12. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311–1320.

13. Brockmann P, Wiechers C, Pantalitschka T, Diebold J, Vagedes J, Poets C. Under-recognition of alarms in a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2013;98(6):524–527.

14. Razi N, Humphreys J, Pandit P, Stahl G. Predischarge monitoring of preterm infants. Pediatr Pulmonol. 1999;27(2):113–116.

15. Harris D, Weston P, Harding J. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161(5):787–791.

Most read articles by the same author(s)